These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2850197)

  • 1. Opioid kappa receptors correlate with the development of conditioned suppression of motility in mice.
    Nabeshima T; Kamei H; Kameyama T
    Eur J Pharmacol; 1988 Jul; 152(1-2):129-33. PubMed ID: 2850197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditioned suppression and opioid kappa receptor in mice.
    Nabeshima T; Kamei H; Matsuno K; Kameyama T
    J Pharmacobiodyn; 1986 Jan; 9(1):74-80. PubMed ID: 3012059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracerebroventricular administration of kappa-agonists induces convulsions in mice.
    Bansinath M; Ramabadran K; Turndorf H; Shukla VK
    Brain Res Bull; 1991 Jul; 27(1):75-9. PubMed ID: 1657321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences of alteration in opioid systems induced by conditioned suppression and electric footshock in mice.
    Kameyama T; Nabeshima T; Yamada K
    Pharmacol Biochem Behav; 1985 Feb; 22(2):249-54. PubMed ID: 2984703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
    Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential antagonism of bremazocine- and U69,593-induced antinociception by quadazocine: further functional evidence of opioid kappa receptor multiplicity in the mouse.
    Horan PJ; de Costa BR; Rice K; Haaseth RC; Hruby VJ; Porreca F
    J Pharmacol Exp Ther; 1993 Aug; 266(2):926-33. PubMed ID: 8394923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of kappa opioid receptors in the rabbit ear artery.
    Berzetei IP; Fong A; Yamamura HI; Duckles SP
    Eur J Pharmacol; 1988 Jul; 151(3):449-55. PubMed ID: 2905660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereospecific inhibition of gastrointestinal transit by kappa opioid agonists in mice.
    Ramabadran K; Bansinath M; Turndorf H; Puig MM
    Eur J Pharmacol; 1988 Oct; 155(3):329-31. PubMed ID: 2853069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facilitation of memory retrieval by pretest morphine mediated by mu but not delta and kappa opioid receptors.
    Shiigi Y; Takahashi M; Kaneto H
    Psychopharmacology (Berl); 1990; 102(3):329-32. PubMed ID: 2174567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys.
    Negus SS; Mello NK; Linsenmayer DC; Jones RM; Portoghese PS
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):412-9. PubMed ID: 12373442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of chronic lithium treatment upon the motivational effects of opioids: alteration in the effects of mu- but not kappa-opioid receptor ligands.
    Shippenberg TS; Herz A
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1101-6. PubMed ID: 1848627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The stereoselective kappa-opioid receptor antagonist Mr 2266 does not exhibit stereoselectivity as an antagonist at the orphan opioid (ORL1) receptor.
    Bauer U; Nakazi M; Kathmann M; Göthert M; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan; 359(1):17-20. PubMed ID: 9933145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of mu and kappa opioid systems on motivational processes.
    Shippenberg TS; Herz A
    NIDA Res Monogr; 1986; 75():563-66. PubMed ID: 2829003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Place-conditioning properties of mu, kappa, and sigma opioid agonists.
    Iwamoto ET
    Alcohol Drug Res; 1985-1986; 6(5):327-39. PubMed ID: 3011025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade.
    Pugsley MK; Penz WP; Walker MJ; Wong TM
    Br J Pharmacol; 1992 Mar; 105(3):521-6. PubMed ID: 1320979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential antagonism of U69,593- and bremazocine-induced antinociception by (-)-UPHIT: evidence of kappa opioid receptor multiplicity in mice.
    Horan P; de Costa BR; Rice KC; Porreca F
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1154-61. PubMed ID: 1646325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-dimensional analyses of behavior in mice treated with U-50,488H, a purported kappa (non-mu) opioid agonist.
    Ukai M; Kameyama T
    Brain Res; 1985 Jul; 337(2):352-6. PubMed ID: 2992682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
    Scheurer U; Wenger F; Caliezi A; Drack E; Varga L; Halter F
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1324-30. PubMed ID: 1969475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory activity of mu- and kappa-selective opioid agonists.
    Taub DD; Eisenstein TK; Geller EB; Adler MW; Rogers TJ
    Proc Natl Acad Sci U S A; 1991 Jan; 88(2):360-4. PubMed ID: 1846441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the kappa opioid agonist R-84760 on cocaine-induced increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice.
    Zhang Y; Butelman ER; Schlussman SD; Ho A; Kreek MJ
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):146-52. PubMed ID: 14712342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.